Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Feb 26, 2024
Open Peer Review Period: Feb 26, 2024 - Feb 27, 2024
Date Accepted: Feb 27, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Correction: A Novel Convolutional Neural Network for the Diagnosis and Classification of Rosacea: Usability Study

Zhao Z, Wu CM, Zhang S, He F, Liu F, Wang B, Huang Y, Shi W, Jian D, Xie H, Yeh CY, Li J

Correction: A Novel Convolutional Neural Network for the Diagnosis and Classification of Rosacea: Usability Study

JMIR Med Inform 2024;12:e57654

DOI: 10.2196/57654

PMID: 38457810

PMCID: 10960214

Addendum to the Acknowledgements: A Novel Convolutional Neural Network for the Diagnosis and Classification of Rosacea: Usability Study

  • Zhixiang Zhao; 
  • Che-Ming Wu; 
  • Shuping Zhang; 
  • Fanping He; 
  • Fangfen Liu; 
  • Ben Wang; 
  • Yingxue Huang; 
  • Wei Shi; 
  • Dan Jian; 
  • Hongfu Xie; 
  • Chao-Yuan Yeh; 
  • Ji Li

ABSTRACT

not applicable


 Citation

Please cite as:

Zhao Z, Wu CM, Zhang S, He F, Liu F, Wang B, Huang Y, Shi W, Jian D, Xie H, Yeh CY, Li J

Correction: A Novel Convolutional Neural Network for the Diagnosis and Classification of Rosacea: Usability Study

JMIR Med Inform 2024;12:e57654

DOI: 10.2196/57654

PMID: 38457810

PMCID: 10960214

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.